We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Novacyt S.a. | LSE:NCYT | London | Ordinary Share | FR0010397232 | EUR1/15TH (CDI) |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.90 | 1.32% | 69.00 | 68.00 | 70.00 | 68.60 | 68.00 | 68.00 | 97,341 | 16:35:08 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
In Vitro,in Vivo Diagnostics | 22.49M | -25.73M | - | N/A | 0 |
Date | Subject | Author | Discuss |
---|---|---|---|
25/10/2020 15:45 | #novacyt #ncyt $alnovAnyone serious about investing in NCYT should read novacytinsider.comBe | routy | |
25/10/2020 15:34 | Filter applied. | bobdown2 | |
25/10/2020 15:10 | That's where the microgen information lies. It cuts out all the disinformation. | bobdown2 | |
25/10/2020 15:02 | GOOD POINT, reference! but the rubbish you are referring to here has only been recently as the price has risen. success, always attracts the inquisitive, the jealous and the i wish i had bought some! | abbynat | |
25/10/2020 14:30 | Although their applications are used in 132 countries, so far everyone seems to be focusing on the UK, contracts with NHS. Other potential with Care Homes, Airports etc and the major Lighthouse Testing Centres. What doesn't seem to have been considered yet is the potential of their release of the 2 Gene Test. although they are principially a french company, France, India the UAE require this 'belt and braces' test. So their next trading update should include revenues coming from these so far untapped streams. No reason why the revenues there should be less than the UK. Then of course there's Winterplex and who knows what that might bring. If you bother to watch to their AGM Video, you will see they say that Covid 19 testing is likely to go on well into 2021, even if a vaccine is approved and released shortly. Recommend everyone follows @NovacytInsider on Twitter where you will get a wealth of real information and not the 90% of real rubbish, bad language and pie in the sky valuations you get here. | referencepoint | |
25/10/2020 14:29 | Qpcr.products.from.p | bobdown2 | |
25/10/2020 13:42 | Hi..earlier.. some discussion was about was possible care home revenue. I have since come across the latest " the novacyt insider ". It shows an antigen and antibody test machine. Very small but very functional. Suitable for hospitals and doctors etc. But also it chucks some numbers into areas that we are looking for. People know my limitations.. it is out there go and get it.. the novacyt investor.. probably updated.. the microgen tester is a little bit bigger than a mobile phone across its base.. | bobdown2 | |
25/10/2020 13:07 | Could be a big week coming up. Not invested here as much as LTH, just enough as all in ODX . But technically it could hit 1800p to 2000p on the next run. Just the right news and woosh. Those that got in sub 100p and HELD are very lucky. Mortgage paid off, nice cars, nice holidays, all done and dusted for many. | oilisgold | |
25/10/2020 12:16 | Oranolio The first link doesn't work but if confirmed we will see 15£ by 8:49 tmrw ffs! | the patient investor | |
25/10/2020 11:22 | Key point £469.3 million Gov contracts for NCYT / Primer Design in October.RNS only stated minimum £150 million so market still valuing NCYT on only £150 million contract!!All broker notes just based on £150 million so up to 3 times undervalued IMO. | routy | |
25/10/2020 11:08 | Tx bob If we are the yardstick, well, not much to add! A billion company in the making, as a xmas present. Very very reali(yard)stic. | the patient investor | |
25/10/2020 10:47 | It could very well be the first sign of a successful trial. But the other mention which I have given and no one has taken on board is the previous trials in southampton that involved Quigliagen trials using primerdesign as a yardstick. Primerdesign has got a large contract and Quigliagen are no where to be seen. There are twitter rumours of test machines on order to test patients before they go on wards. The samba machines and fudge nudge may not be able to handle the volume and have they had problems. I think that it does not matter where they are sold if qpcr production is being stepped up dramatically. However long term testing in care homes worldwide is the biggie. | bobdown2 | |
25/10/2020 10:11 | Do you bob think the increased urgent demand for qpcr 16/32 related staff is due to the imminent supply to carehomes? | the patient investor | |
25/10/2020 09:39 | Being mentioned over on sharechat is a tweet that suggests an extra 10,000 tests a day going through the cambridge lighthouse. The tweet has been liked by someone at astra zeneca The lighthouse system is the uk.s major test centres. However lots want to see more decentralisation. And that could come very shortly as the results from the carehome trials become known. Extra staff have already filled or vacancies advertised for the increased production of the qpcr16 and 32 machines. Double bubble... lighthouse tests and care homes. | bobdown2 | |
25/10/2020 09:34 | You'll have to show us a picture of this Aston. | nicktrade81 | |
25/10/2020 09:15 | 15 pounds end of next week is possible. Picking up my AstonMartin next Wednesday. Guess where the money came from, Covid stocks. Once the vaccination is out , most Covid stocks will disappear in no man lands. Easy money has been made. NCYT in prime position. | oilisgold |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions